Citation: G. Bartsch et al., Dihydrotestosterone and the concept of 5 alpha-reductase inhibition in human benign prostatic hyperplasia, EUR UROL, 37(4), 2000, pp. 367-380
Authors:
Thomas, LN
Wright, AS
Lazier, CB
Cohen, P
Rittmaster, RS
Citation: Ln. Thomas et al., Prostatic involution in men taking finasteride is associated with elevatedlevels of insulin-like growth factor-binding proteins (IGFBPs)-2,-4, and-5, PROSTATE, 42(3), 2000, pp. 203-210
Authors:
Rittmaster, RS
Bolognese, M
Ettinger, MP
Hanley, DA
Hodsman, AB
Kendler, DL
Rosen, CJ
Citation: Rs. Rittmaster et al., Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J CLIN END, 85(6), 2000, pp. 2129-2134
Authors:
Kreiger, N
Tenenhouse, A
Joseph, L
Mackenzie, T
Poliquin, S
Brown, JP
Prior, JC
Rittmaster, RS
Citation: N. Kreiger et al., Research notes: The Canadian multicentre osteoporosis study (CaMos): Background, rationale, methods, CAN J AGING, 18(3), 1999, pp. 376-387
Authors:
Rittmaster, RS
Thomas, LN
Wright, AS
Murray, SK
Carlson, K
Douglas, RC
Yung, J
Messieh, M
Bell, D
Lazier, CB
Citation: Rs. Rittmaster et al., The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer, J UROL, 162(6), 1999, pp. 2165-2169
Citation: As. Wright et al., Androgen-induced regrowth in the castrated rat ventral prostate: Role of 5alpha-reductase, ENDOCRINOL, 140(10), 1999, pp. 4509-4515